Announced Fri, 26 Jun · 19:08 IST
Trading window closure ahead of Q1 FY27 results
Compliance View source PDF
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹373.50
prior close
₹372.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.1-0.3+1.1+2.4+1.4+3.1+3.4+1.6+4.4+12.3———
Up moveDown movePending
AI summary
Aarti Drugs has closed its trading window from July 1, 2026 until 48 hours after the declaration of financial results for the quarter ended June 30, 2026. This is a standard SEBI insider trading regulation compliance measure taken ahead of the quarterly results announcement. The window closure restricts insiders, directors, and connected persons from trading in the company's shares during this period.
Likely market impact
Routine pre-results compliance. Insiders cannot trade shares until about 2 days after Q1 FY27 results are declared.